[Progress and perspectives in palliative therapy of breast carcinoma].
Verlag
G T
GT
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000077143:Docetaxel; D005260:Female; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D010166:Palliative Care; D013629:Tamoxifen / Q000627:therapeutic use; D043823:Taxoids
D000903:Antibiotics, Antineoplastic; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D047072:Aromatase Inhibitors; D043823:Taxoids; D013629:Tamoxifen; D017273:Goserelin; D000077143:Docetaxel; D017239:Paclitaxel